|
Chemical Identification/RIDS
<br />Molecular Weight: 57.95 (EPA, 1998)
<br />TLV TWA: 2 mg/m3 As Al. (ACGIH, 2003)
<br />TEEL1: 4 mg/m3 (TEEL, 2003)
<br />TEEL2: 20 mg/m3 (TEEL, 2003)
<br />TEEL3: 20 mg/m3 (TEEL, 2003)
<br />Specific Gravity: 2.85 at 59° F (EPA, 1998_)
<br />First Aid
<br />Warning: Effects may be delayed for several hours. Caution is advised.
<br />Signs and Symptoms of Acute Aluminum Phosphide Exposure: Acute exposure to aluminum phosphide usually results in headache, cough,
<br />tightness and pain in the chest, shortness of breath, dizziness, lethargy, and stupor. Muscle pain, fatigue, chills, tremor, lack of
<br />coordination, seizures, and coma may be observed. Pulmonary edema and cardiac irregularities are also commonly found.
<br />Gastrointestinal effects include nausea, vomiting, abdominal pain, and diarrhea. Renal (kidney) damage, hepatic (liver) damage, and
<br />jaundice may also occur. Contact with aluminum phosphide may cause severe burns to skin and eyes.
<br />Emergency Life -Support Procedures: Acute exposure to aluminum phosphide may require decontamination and life support for the victims.
<br />Emergency personnel should wear protective clothing appropriate to the type and degree of contamination. Air -purifying or supplied -air
<br />respiratory equipment should also be worn, as necessary. Rescue vehicles should carry supplies such as plastic sheeting and disposable
<br />plastic bags to assist in preventing spread of contamination.
<br />Inhalation Exposure:
<br />1. Move victims to fresh air. Emergency personnel should avoid self -exposure to aluminum phosphide.
<br />2. Evaluate vital signs including pulse and respiratory rate, and note any trauma. If no pulse is detected, provide CPR. If not breathing,
<br />provide artificial respiration. If breathing is labored, administer oxygen or other respiratory support.
<br />3. Obtain authorization and/or further instructions from the local hospital for administration of an antidote or performance of other invasive
<br />procedures.
<br />4. Transport to a health care facility.
<br />Dermal/Eye Exposure:
<br />1. Remove victims from exposure. Emergency personnel should avoid self- exposure to aluminum phosphide.
<br />2. Evaluate vital signs including pulse and respiratory rate, and note any trauma. If no pulse is detected, provide CPR. If not breathing,
<br />provide artificial respiration. If breathing is labored, administer oxygen or other respiratory support.
<br />3. Remove contaminated clothing as soon as possible.
<br />4. If eye exposure has occurred, eyes must be flushed with lukewarm water for at least 15 minutes.
<br />5. Wash exposed skin areas twice with soap and water.
<br />6. Obtain authorization and/or further instructions from the local hospital for administration of an antidote or performance of other invasive
<br />procedures.
<br />7. Transport to a health care facility.
<br />Ingestion Exposure: No information is available. (EPA, 1998)
<br />Reactivity
<br />AIR AND WATER REACTIONS:
<br />Decomposed by water or moist air, evolving phosphine, a toxic gas that often ignites [Merck 11th ed. 1989].
<br />CHEMICAL PROFILE:
<br />ALUMINUM PHOSPHIDE is a reducing agent. Contact with mineral acids causes explosive evolution of toxic phosphine [Wang, C. C. et
<br />al., J. Inorg. Nucl. Chem., 1963, 25, p. 327]. Heating produces highly toxic fumes of phosphorus oxides. Can react vigorously upon contact
<br />with oxidizing agents. [Sax, 9th ed., p. 119].
<br />REACTIVE GROUPS:
<br />Nitrides, Phosphides, Carbides, and Silicides, Inorganic (REACTIVITY, 2003)
<br />Reactive Hazards
<br />Strong Reducing Agent, Water -Reactive, Air -Reactive
<br />6/12/2007 Printed from CAMEO Page 2
<br />
|